ISPOR - HPR236 Value of Patient-Reported Outcomes Data in Food and Drug Administration Labeling of Oncology Drugs to Payers in the United States

Full Text

HPR236 Value of Patient-Reported Outcomes Data in Food and Drug Administration Labeling of Oncology Drugs to Payers in the United States

Abstract

Authors

Stephen Ijioma Heiko Zettl Nicholas Liu Audra Gold Mark Price Marci Clark

Back to Volume 28, Supplemental Issue 12S1

Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now